Radioresponsiveness of human glioma, sarcoma, and breast cancer spheroids depends on tumor differentiation.

作者: Martin Stuschke , Volker Budach , Horst Sack

DOI: 10.1016/0360-3016(93)90389-D

关键词: RadiosensitivityGliomaClonogenic assayPathologyRadiation therapySarcomaTumor progressionMedicineSpheroidCellular differentiation

摘要: Abstract Purpose: Differences in the intrinsic radiosensitivity within and between different tumor classes have been noticed for human cell lines using clonogenic assay. By far, most of studied up to now were derived from poorly differentiated tumors. In this study, influence differentiation on radiation doses necessary control 50% small oxic spheroids (SCD 50 ) was determined. Evidence a distinct dependence radioresponsiveness progression provides background an investigation underlying mechanisms. Methods Materials: Spheroids aggregated 1000–1500 cells agarose coated 24 multi-well plates. Their diameters ranged 156 405 μm, depending line. irradiated with graded 60 Co single spheroid as end point minimum follow-up period 3 months. Results: Cell three low grade gliomas 10 malignant The group mean SCD values 6.1 ± 1.6 Gy 13.1 3.3 Gy, respectively. Four 2 soft tissue sarcomas had value 6.2 0.5 one undifferentiated sarcoma line 11.0 Gy. Three well-differentiated breast cancer expressed adhesion molecule E-cadherin, epitheloid morphology monolayer culture, estrogen receptor positive or contact inhibited multicellular spheroids. Two fibroblastoid marker negative. former 10.5 1.0 while that 14.8 2.8 Analysis variance revealed significant effect type well dedifferentiation after irradiation fraction 2Gy/fraction. surviving fractions at (SF2), obtained rates fractionation schedules by approximation linear quadratic model assuming Poisson statistics significantly dependent ( p = 0.001, ANOVA F-test) but not 0.27). αβ ratios did depend 0.08, F-Test) increased 0.03). Conclusion: is suitable measuring very colony forming efficiencies. Tumor important factor recovery capacity cells.

参考文章(60)
J. R. Mcculloch, J. R. Giblin, D. V. Dougherty, M. L. Rosenblum, H. Kleppe-Hoifodt, J. T. Rutka, D. A. Emma, S. J. De Armond, Characterization of normal human brain cultures. Evidence for the outgrowth of leptomeningeal cells. Laboratory Investigation. ,vol. 55, pp. 71- 85 ,(1986)
M. Westphal, M. Hänsel, H. Nausch, E. Rohde, J. Köppen, M. Fiola, F. Hölzel, H.-D. Herrmann, Glioma Biology in vitro: Goals and Concepts Proceedings of the 8th European Congress of Neurosurgery, Barcelona, September 6–11, 1987. ,vol. 43, pp. 107- 113 ,(1988) , 10.1007/978-3-7091-8978-8_23
J Fantini, J B Rognoni, M Roccabianca, G Pommier, J Marvaldi, Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4 Journal of Biological Chemistry. ,vol. 264, pp. 10282- 10286 ,(1989) , 10.1016/S0021-9258(18)81797-5
Linda W. Engel, Nathaniel A. Young, Human breast carcinoma cells in continuous culture: a review. Cancer Research. ,vol. 38, pp. 4327- 4339 ,(1978)
Lynn A. Gaskins, Paul Calabresi, John T. Leith, Daniel L. Dexter, Arvin S. Glicksman, Alteration of the Survival Response of Two Human Colon Carcinoma Subpopulations to X-Irradiation by N,N-Dimethylformamide Cancer Research. ,vol. 42, pp. 30- 34 ,(1982)
J.H. Hendry, C.S. Potten, Alpha/beta ratios and the cycling status of tissue target cells. Radiotherapy and Oncology. ,vol. 12, pp. 79- 83 ,(1988) , 10.1016/0167-8140(88)90194-6
CA Bill, CM Vines, KC Garrett, K Yamada, PJ Tofilon, Enhancement of the radiosensitivity of two human tumour cell lines by hexamethylene bisacetamide. British Journal of Cancer. ,vol. 61, pp. 563- 567 ,(1990) , 10.1038/BJC.1990.126
John T. Fazekas, Treatment of grades I and II brain astrocytomas. The role of radiotherapy. International Journal of Radiation Oncology Biology Physics. ,vol. 2, pp. 661- 666 ,(1977) , 10.1016/0360-3016(77)90045-1